Argenx Se (ARGX) Short-term Investments (2015 - 2025)

Argenx Se (ARGX) posted Short-term Investments of $948.8 million for Q4 2025, down 99.95% on a QoQ basis from $1842.2 billion in Q2 2025, and down 49.5% year-over-year from $1.9 billion in Q4 2024.

Argenx Se (ARGX) Short-term Investments (2015 - 2025) Analysis & Trends

Argenx Se's Short-term Investments history runs 11 years deep, the most recent figure standing at $948.8 million for Q4 2025.

  • Quarterly Short-term Investments fell 49.5% year-over-year to $948.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $948.8 million (down 49.5% YoY) and the FY2025 annual result came in at $2.4 billion, up 209.38% from the prior year.
  • Short-term Investments was $948.8 million for Q4 2025 at Argenx Se, down from $1842.2 billion in the prior quarter.
  • Across five years, Short-term Investments topped out at $1842.2 billion in Q2 2025 and bottomed at -$1108.4 billion in Q2 2024.
  • A 5-year average of $74.3 billion and a median of $1.1 billion in 2021 frame the typical range for Short-term Investments.
  • Annual changes were most pronounced in 2024 — Short-term Investments tumbled 125146.11% — and 2025, when it soared 266.2%.
  • Argenx Se's Short-term Investments stood at $1.0 billion in 2021, then surged by 38.9% to $1.4 billion in 2022, then retreated by 18.74% to $1.1 billion in 2023, then soared by 66.13% to $1.9 billion in 2024, then plunged by 49.5% to $948.8 million in 2025.
  • Business Quant data shows ARGX's Short-term Investments at $948.8 million in Q4 2025, $1842.2 billion in Q2 2025, and $1.9 billion in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 948.75 Mn
Jun 30, 2025 1,842.20 Bn
Dec 31, 2024 1.88 Bn
Jun 30, 2024 -1,108.41 Bn
Dec 31, 2023 1.13 Bn
Jun 30, 2023 886.40 Mn
Dec 31, 2022 1.39 Bn
Jun 30, 2022 1.23 Bn
Dec 31, 2021 1.00 Bn
Jun 30, 2021 1.15 Bn
Dec 31, 2020 757.53 Mn
Jun 30, 2020 805.56 Mn
Dec 31, 2019 1.11 Bn
Jun 30, 2019 872.49 Mn
Dec 31, 2018 323.62 Mn
Jun 30, 2018 236.28 Mn
Dec 31, 2017 198.88 Mn
Jun 30, 2017 107.64 Mn
Dec 31, 2016 7.38 Mn
Dec 31, 2015 7.47 Mn